Site-Specific Antibody for Protein Poly-ADP-Ribosylation
蛋白质聚 ADP 核糖基化位点特异性抗体
基本信息
- 批准号:10610163
- 负责人:
- 金额:$ 24.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Poly-ADP-ribosylation (PARylation) is a protein posttranslational modification (PTM) that is catalyzed by
a family of enzymes known as Poly-ADP-ribose polymerases (PARPs). Among the various PARP family
members, PARP1 is a nuclear enzyme that is critically involved in cell stress responses. Upon sensing DNA
strand breaks, PARP1 becomes activated, and then utilizes the cofactor, NAD+ to synthesize a large array of
PARylated proteins. These protein-linked PAR chains serve as a platform to recruit the DNA repair machinery,
and to initiate the DNA damage response (DDR). These findings provide the rationale to develop PARP1
inhibitors to treat human malignancies. Indeed, four PARP1 inhibitors have been recently approved by the FDA
to treat BRCA-deficient ovarian and/or breast cancer patients. Despite the exciting progresses of PARP1
inhibitors in the clinic, the basic signaling mechanism of PARP1 and the related PARP enzymes remains
poorly understood. The analysis of protein PARylation represents a daunting challenge, owing to the low-
abundance, labile and heterogeneous nature of this PTM. As a result, very few genuine PARP1 substrates
(and their modification sites) have been identified, and in most of the cases, how PARylation regulates the
function of the DNA damage responsive proteins is poorly defined. Recently, we developed the first large-scale
mass spectrometric (MS) approach towards site-specific characterization of protein Asp-/Glu-PARylation.
Although this strategy enables the quantitative assessment of the PARylated proteome, it is a quite lengthy
procedure that requires the access to both mass spectrometry equipment and computational proteomics
software. Furthermore, current anti-PAR antibodies only allow the analysis of the level of total PARylation, but
not PARylation at a specific residue. In this proposal, we will develop a chemical biology approach towards the
development of general site-specific PARylation antibodies. We will select a number of PARylation targets that
are critically involved in DDR, and the corresponding antibodies will be evaluated using cell systems and
animal models. We envision that the development of antibodies that allow for the simple, sensitive, specific and
rapid detection of PARylation sites would greatly facilitate the understanding the role of PARylation in DDR and
cancer. We also expect that this approach will be highly useful for the future development of biomarkers
targeting these aberrant “protein modification signatures”.
聚 ADP 核糖基化 (PARylation) 是一种蛋白质翻译后修饰 (PTM),由以下物质催化:
称为聚 ADP 核糖聚合酶 (PARP) 的酶家族。在各种 PARP 家族中
PARP1 是一种核酶,与细胞应激反应密切相关。感测 DNA 后
链断裂,PARP1 被激活,然后利用辅因子 NAD+ 合成大量
PARylated 蛋白质。这些蛋白质连接的 PAR 链作为招募 DNA 修复机制的平台,
并启动 DNA 损伤反应 (DDR)。这些发现为开发 PARP1 提供了理论依据
治疗人类恶性肿瘤的抑制剂。事实上,FDA 最近批准了四种 PARP1 抑制剂
治疗缺乏 BRCA 的卵巢癌和/或乳腺癌患者。尽管 PARP1 取得了令人兴奋的进展
临床上的抑制剂,PARP1和相关PARP酶的基本信号机制仍然存在
不太了解。蛋白质 PARylation 的分析是一项艰巨的挑战,因为
该 PTM 的丰富性、不稳定性和异质性。因此,真正的 PARP1 底物很少
(及其修饰位点)已被确定,并且在大多数情况下,PARylation 如何调节
DNA损伤反应蛋白的功能尚不清楚。最近,我们开发了第一个大型
蛋白质 Asp-/Glu-PARylation 的位点特异性表征的质谱 (MS) 方法。
尽管该策略能够对 PARylated 蛋白质组进行定量评估,但它是一个相当漫长的过程
需要使用质谱设备和计算蛋白质组学的程序
软件。此外,目前的抗 PAR 抗体只能分析总 PARylation 的水平,但
不是在特定残基上进行 PARylation。在本提案中,我们将开发一种化学生物学方法
通用位点特异性 PARylation 抗体的开发。我们将选择一些 PARylation 目标
与 DDR 密切相关,将使用细胞系统和相应的抗体进行评估
动物模型。我们设想开发出能够简单、灵敏、特异性和
快速检测 PARylation 位点将极大地促进了解 PARylation 在 DDR 和
癌症。我们还期望这种方法对于生物标志物的未来开发非常有用
针对这些异常的“蛋白质修饰特征”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yonghao Yu其他文献
Yonghao Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yonghao Yu', 18)}}的其他基金
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10524783 - 财政年份:2022
- 资助金额:
$ 24.76万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10610165 - 财政年份:2022
- 资助金额:
$ 24.76万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10389853 - 财政年份:2021
- 资助金额:
$ 24.76万 - 项目类别:
Site-Specific Antibody for Protein Poly-ADP-Ribosylation
蛋白质聚 ADP 核糖基化位点特异性抗体
- 批准号:
10231962 - 财政年份:2021
- 资助金额:
$ 24.76万 - 项目类别:
Posttranslational Regulation of Cell Growth and Stress Responses
细胞生长和应激反应的翻译后调节
- 批准号:
10676253 - 财政年份:2020
- 资助金额:
$ 24.76万 - 项目类别:
Posttranslational Regulation of Cell Growth and Stress Responses
细胞生长和应激反应的翻译后调节
- 批准号:
10610164 - 财政年份:2020
- 资助金额:
$ 24.76万 - 项目类别:
Mass spectrometric approaches to protein ADP-ribosylation
蛋白质 ADP 核糖基化的质谱方法
- 批准号:
9568790 - 财政年份:2017
- 资助金额:
$ 24.76万 - 项目类别:
Molecular and Biochemical Basis of mTORC1-mediated Feedback Loops
mTORC1 介导的反馈环的分子和生化基础
- 批准号:
9143156 - 财政年份:2015
- 资助金额:
$ 24.76万 - 项目类别:
Molecular and Biochemical Basis of mTORC1-mediated Feedback Loops
mTORC1 介导的反馈环的分子和生化基础
- 批准号:
9341365 - 财政年份:2015
- 资助金额:
$ 24.76万 - 项目类别:
相似国自然基金
花胶鱼类物种Species-specific PCR和Multiplex PCR鉴定体系研究
- 批准号:31902373
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation
开发一种简便、稳健、可扩展且多功能的化学酶聚糖重塑方法,用于位点特异性抗体缀合
- 批准号:
10615237 - 财政年份:2022
- 资助金额:
$ 24.76万 - 项目类别:
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation
开发一种简便、稳健、可扩展且多功能的化学酶聚糖重塑方法,用于位点特异性抗体缀合
- 批准号:
10484443 - 财政年份:2022
- 资助金额:
$ 24.76万 - 项目类别:
Targeting breast cancer via site-specific antibody-drug conjugates based on biosynthetically modified enediyne natural products
通过基于生物合成修饰的烯二炔天然产物的位点特异性抗体药物缀合物靶向乳腺癌
- 批准号:
514898299 - 财政年份:2022
- 资助金额:
$ 24.76万 - 项目类别:
WBP Fellowship
Site-Specific Antibody for Protein Poly-ADP-Ribosylation
蛋白质聚 ADP 核糖基化位点特异性抗体
- 批准号:
10231962 - 财政年份:2021
- 资助金额:
$ 24.76万 - 项目类别:
Generation of Antibody Drug Conjugate (ADC) technologies for site specific conjugation to toxins
生成用于与毒素进行位点特异性缀合的抗体药物缀合物 (ADC) 技术
- 批准号:
2395805 - 财政年份:2020
- 资助金额:
$ 24.76万 - 项目类别:
Studentship
Preparation of site-specific antibody-drug conjugates by proximity-based sortase ligation
通过基于邻近的分选酶连接制备位点特异性抗体-药物缀合物
- 批准号:
9404082 - 财政年份:2017
- 资助金额:
$ 24.76万 - 项目类别:
Tools for site-specific antibody immobilization for immunoassays
用于免疫测定的位点特异性抗体固定工具
- 批准号:
9253466 - 财政年份:2017
- 资助金额:
$ 24.76万 - 项目类别:
Site-specific antibody-toxin conjugates for cancer therapy
用于癌症治疗的位点特异性抗体-毒素缀合物
- 批准号:
8909974 - 财政年份:2015
- 资助金额:
$ 24.76万 - 项目类别:
Site Specific Antibody Modification Using Catalyst-Functionalized Affinity Beads
使用催化剂功能化亲和珠进行位点特异性抗体修饰
- 批准号:
15K12742 - 财政年份:2015
- 资助金额:
$ 24.76万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Sortase Peptide Technology: Enzymatic Site-specific Bioconjugation to Improve Antibody Drug Conjugate Production and Performance
Sortase 肽技术:酶促位点特异性生物缀合可提高抗体药物缀合物的生产和性能
- 批准号:
nhmrc : 1039017 - 财政年份:2012
- 资助金额:
$ 24.76万 - 项目类别:
Development Grants